Entropy Technologies’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Buy
19,080
+7,587
+66% +$213K 0.02% 653
2026
Q1
$328K Buy
11,493
+2,408
+27% +$82.2K 0.02% 683
2025
Q4
$359K Buy
+9,085
New +$333K 0.02% 655
2025
Q2
Sell
-6,990
Closed -$225K 781
2025
Q1
$225K Buy
+6,990
New +$259K 0.02% 607
2024
Q1
Sell
-9,933
Closed -$355K 712
2023
Q4
$355K Buy
+9,933
New +$369K 0.07% 410

Other funds holding ATRC

Entropy Technologies's ATRC Position: Q2 2026 in Review

Entropy Technologies increased its AtriCure (ATRC) stake by 66% in Q2 2026, buying an estimated $213K and bringing the position to 19,080 shares worth $534K. The position accounts for 0.02% of the portfolio, ranked #653.

Entropy Technologies first reported a position in ATRC in Q4 2023 and has held it in 5 quarters since. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Entropy Technologies held 19,080 shares of AtriCure worth $534K as of Q2 2026.
  • Entropy Technologies bought 7,587 AtriCure shares in Q2 2026, an estimated $213K.
  • AtriCure made up 0.02% of Entropy Technologies's portfolio in Q2 2026, its #653 holding.
  • Entropy Technologies first reported a position in AtriCure in Q4 2023 and has held it in 5 quarters since.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.